IQVIA Holdings Inc IQV has posted Q4 adjusted EPS of $2.55, up 20.9% Y/Y, surpassing the consensus of $2.43.
- Revenue of $3.64 billion increased 10.2% on a reported basis and 11.6% at constant currency, ahead of the consensus of $3.59 billion.
- Technology & Analytics Solutions' revenue of $1.49 billion grew 5% on a reported basis and 6.6% at constant currency.
- Research & Development Solutions (R&DS) revenue increased 15.4% on a reported basis and 16.3% at constant currency to $1.94 billion.
- R&D Solutions contracted backlog of $24.8 billion grew 10.2% Y/Y.
- Adjusted EBITDA increased 12.7% to $828 million.
- Share Buyback: In February, the IQVIA board approved an increase of the share repurchase authorization by $2.0 billion, bringing the remaining authorization to just over $2.5 billion.
- Outlook: For FY22, IQVIA is reaffirming the revenue guidance of $14.7 billion - $15 billion (consensus of $14.97 billion), despite a $70 million revenue headwind from changes in foreign currency exchange rates.
- The company is raising the Adjusted EBITDA outlook to $3.33 billion - $3.41 billion, and Adjusted EPS guidance to $9.95 - $10.25 (consensus of $10.14).
- For Q1, the company expects revenue of $3.515 billion - $3.575 billion (consensus $3.63 billion). It sees Q1 Adjusted EPS of $2.40 - $2.46, against the consensus of $2.44.
- Price Action: IQV shares closed lower by 1.79% at $239.90 on Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in